Dr Alvin Fox

Ph.D. University of Leeds

Post-doctoral Fellowships
University of Texas Health Science Center, Dallas
University of North Carolina School of Medicine

Professor of Pathology, Microbiology and Immunology



Office: 803 733 3288
Fax: 803 733 3192

Department of Pathology and Microbiology, University of South Carolina School of Medicine, Columbia, SC 29208

Dr Fox's curriculum vitae is here (PDF file)

Recent Publications


Our research interest relates to biodefense and homeland security encompassing proteomics. We are developing a novel anthrax vaccine funded by NIH. A carbohydrate was discovered, by our group, which surrounds the spore of Bacillus anthracis that was subsequently shown to be a component of two glycoproteins. These glycoproteins are serving as the focus for our vaccine studies. The spore is the infective agent and thus the earliest stage of the disease process is being targeted. The current US anthrax vaccine for human use involves a later stage of the disease, when the dormant spore has germinated into a vegetative form, and produced a life-threatening lethal toxin. Other interests are in the area of diagnostics relating to biodetection (rapid detection of a biological warfare attack) and forensics (source verification, e.g. the Amerithrax attacks on the US postal service). Dr. Fox is the Editor-in-Chief of the Journal of Microbiological Methods, joint-Editor-in-Chief of Molecular and Cellular Probes and is on the Editorial board of the Journal of Clinical Microbiology.

Learn about the research of other faculty

     This page copyright 2006 The Board of Trustees of the University of South Carolina